| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.843 | 37.281 | 30.405 | 21.374 | 35.078 | 60.047 | 73.346 | 82.871 |
| Total Income - EUR | - | - | 2.855 | 37.309 | 30.461 | 21.389 | 35.089 | 60.091 | 74.964 | 83.033 |
| Total Expenses - EUR | - | - | 5.509 | 40.725 | 39.836 | 27.709 | 35.954 | 52.316 | 59.417 | 59.560 |
| Gross Profit/Loss - EUR | - | - | -2.654 | -3.416 | -9.375 | -6.319 | -866 | 7.775 | 15.547 | 23.473 |
| Net Profit/Loss - EUR | - | - | -2.739 | -4.535 | -10.288 | -6.911 | -1.918 | 5.974 | 12.587 | 19.397 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Symbiotic Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 19.940 | 15.870 | 11.909 | 8.325 | 4.690 | 1.758 |
| Current Assets | - | - | 1.739 | 15.210 | 11.358 | 7.361 | 7.778 | 21.310 | 30.099 | 50.621 |
| Inventories | - | - | 571 | 4.167 | 3.655 | 1.732 | 1.391 | 2.057 | 5.486 | 9.991 |
| Receivables | - | - | 454 | 6.299 | 4.761 | 3.802 | 3.433 | 5.199 | 10.500 | 27.834 |
| Cash | - | - | 714 | 4.744 | 2.942 | 1.827 | 2.954 | 14.055 | 14.113 | 12.796 |
| Shareholders Funds | - | - | -2.520 | -7.009 | -17.161 | -23.746 | -25.137 | -19.242 | -6.596 | 12.838 |
| Social Capital | - | - | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 4.259 | 22.224 | 48.460 | 46.991 | 44.862 | 48.879 | 42.149 | 40.963 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4799
|
|||||||||
Comments - Symbiotic Line Srl